Justice Neil Gorsuch issued a forceful criticism of lower federal courts on Thursday as the Supreme Court delivered a narrow 5–4 ruling granting the Trump administration a significant victory in a dispute over federal research funding.
The Court ruled that the administration may proceed with the suspension of millions of dollars in National Institutes of Health (NIH) grants tied to diversity, equity, and inclusion (DEI) initiatives, gender identity research, and certain COVID-19-related studies. The decision represents a major development in the administration’s broader effort to reshape federal spending priorities and reduce support for programs it considers ideologically driven.
In a concurring opinion joined by Justice Brett Kavanaugh, Justice Gorsuch expressed frustration with what he characterized as a recurring pattern of lower courts failing to follow Supreme Court precedent. He noted that the Court had recently been forced to reverse multiple lower-court rulings involving issues it had already addressed.
Gorsuch emphasized that while lower-court judges are free to disagree with Supreme Court decisions, they remain obligated to apply those rulings faithfully. He argued that attempts to circumvent or disregard established precedent undermine the judiciary’s role and create unnecessary legal uncertainty.
The case originated when U.S. District Judge William Young of Massachusetts ordered the NIH to continue funding the disputed grants. Young concluded that terminating the programs constituted unlawful discrimination against racial minorities and LGBTQ communities. Democratic attorneys general and several public health organizations challenged the administration’s actions, contending that the funding cuts unfairly targeted specific areas of scientific research.
Justice Amy Coney Barrett cast the decisive vote in the majority. However, Barrett also joined Chief Justice John Roberts and the Court’s three liberal justices—Sonia Sotomayor, Elena Kagan, and Ketanji Brown Jackson—in a separate aspect of the case that upheld a lower-court ruling invalidating portions of NIH guidance documents related to agency policy priorities.
The Supreme Court’s decision overturns Judge Young’s order and reaffirms the executive branch’s authority to determine how certain federal research funds are allocated. Since returning to office in 2025, President Donald Trump has signed a series of executive orders aimed at dismantling DEI-related programs across federal agencies.
Legal analysts say the ruling highlights ongoing tensions between the Supreme Court and some lower federal courts regarding the application of precedent. Supporters argue the decision restores neutrality and accountability in taxpayer-funded research, while critics contend it could hinder important scientific studies and increase political influence over research priorities.
The ruling is expected to have lasting implications for executive authority, federal grant administration, and the future direction of government-funded scientific research.
